Biolex is applying its proprietary glycosylation optimization technology to the antibody, BLX-301, to enhance efficacy and potency of the product candidate and potentially reduce certain side effects. Biolex
The contract is valued at approximately $32.3 million over a seven-year period. DynPort Vaccine (DVC) is teaming with Quintiles Transnational to complete this work. Under the terms of
Ms Russell served as partner, director, and senior manager at Insero & Company CPA’s, since 2001. As a partner in the outsource accounting services group, she dealt with
Under the terms of the agreement, Nycomed will be responsible for all costs associated with current and future clinical development, manufacturing and commercialization of veltuzumab in subcutaneous formulation
This designation was granted based on the recommendation of the European Medicines Evaluation Agency (EMEA) following a positive opinion from the Committee for Orphan Medicinal Products. Orphan designation
The Phase III clinical trials in the US and China on which this approval was based demonstrated that Abraxane doubled the response rate, significantly prolonged time to tumor
Under the terms of the agreement, Biologics Delivery Systems will supply catheters for the upcoming Phase I/II clinical trial of Gamida Cell’s CardioCure product for the treatment of
According to TheraGenetics, the strategic expansion into the area of depression underscores the company’s commitment to licensing new technologies to build a foundation for future diagnostic tests for
Merck Sharp & Dohme’s Tredaptive combines nicotinic acid and laropiprant, a novel flushing pathway inhibitor. In clinical studies involving more than 4,700 patients, Tredaptive reduced LDL-cholesterol (LDL-C, or
Hoana’s LifeBed patient vigilance system identifies patients as they begin to deteriorate and immediately notifies the hospital nursing staff – all invisible to the patient since there is
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.